Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1083656

registered interest
date	07/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the savings accrued to the public purse by North Lincolnshire Care Commissioning Group as a result of the implementation of Yorkshire and Humber AHSN’s improved faecal calprotectin pathway for diagnosis of Inflammatory Bowel Disease; and if he will make a statement.
tabling member constituency	Cleethorpes
tabling member printed	Martin Vickers
uin	229672
answer	answer is ministerial correction date of answer 15/03/2019 answer text <p>No estimate has been made. The National Institute for Health and Care Excellence (NICE) recommends faecal calprotectin testing as an option to help doctors distinguish between inflammatory bowel diseases (IBDs), such as Crohn’s disease and ulcerative colitis, and non-IBDs, such as irritable bowel syndrome.</p><p> </p><p>The NICE IBD Quality Standard states that general practitioners (GP) and GP practices should ensure that testing is offered and clinical commissioning groups should ensure the diagnostic services are in place to support this.</p><p> </p><p>NHS England has produced a consensus guidance document that supports implementation of the NICE guidance. Both the guidance and statement can be found at the following link:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/dg11/resources/endorsed-resource-the-use-of-faecal-calprotectin-in-primary-care-as-a-decision-diagnostic-for-inflammatory-bowel-disease-and-irritable-bowel-syndrome-4595859613" target="_blank">www.nice.org.uk/guidance/dg11/resources/endorsed-resource-the-use-of-faecal-calprotectin-in-primary-care-as-a-decision-diagnostic-for-inflammatory-bowel-disease-and-irritable-bowel-syndrome-4595859613</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/03/2019 13:37:36 answering member 4067 label Biography information for Steve Brine
tabling member	3957 label Biography information for Martin Vickers

1047595

registered interest
date	23/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have to (1) review, and (2) update, the NICE guidelines for the management of (a) Crohn’s disease, and (b) ulcerative colitis.
tabling member printed	Baroness Young of Old Scone
uin	HL13088
answer	answer is ministerial correction date of answer 06/02/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for reviewing and updating its guidelines as new evidence becomes available.</p><p>NICE’s clinical guidelines for the management of Crohn’s disease and ulcerative colitis were both reviewed in 2017 and are both in the process of being updated.</p><p>The Crohn’s disease guideline update focuses on postsurgical maintenance of remission, whilst the ulcerative colitis guideline update focuses on medicines used to induce remission in people with mild-to-moderate ulcerative colitis and treating acute severe ulcerative colitis.</p><p>NICE expects to publish its updated guidelines for both conditions in May 2019.</p> answering member printed Baroness Blackwood of North Oxford question first answered 06/02/2019 15:51:08 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1755 label Biography information for Baroness Young of Old Scone

1045624

registered interest
date	21/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people have been diagnosed with inflammatory bowel disease in each of the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	210609
answer	answer is ministerial correction date of answer 24/01/2019 answer text <p>The data is not held in the format requested.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/01/2019 15:30:39 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

895447

registered interest
date	01/05/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding there has been from the public purse for research into treatment of (a) Crohn's disease and (b) ulcerative colitis in the last five years.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	140120
answer	answer is ministerial correction date of answer 10/05/2018 answer text <p>The Department funds research through the National Institute for Health Research (NIHR). NIHR welcomes funding applications for research into any aspect of human health, including Crohn’s disease. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p><p>The NIHR’s support for Crohn’s disease research over the last five years includes £18.2 million funding for research projects, and £10.8 million funding for clinical trials and other high quality studies supported through the NIHR Clinical Research Network.</p><p> </p><p>Summary of NIHR funding for research on Crohn's disease and ulcerative colitis is attached.</p><p> </p><p> </p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 10/05/2018 15:49:51 answering member 4008 label Biography information for Dame Caroline Dinenage attachment 1 file name PQ140120 attached table.docx title PQ140120 attached document
tabling member	4244 label Biography information for Jonathan Ashworth

886240

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps the Government is taking to promote timely and accurate diagnosis of inflammatory bowel disease.
tabling member constituency	Great Grimsby
tabling member printed	Melanie Onn
uin	136435
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>NHS England and clinical commissioning groups (CCGs) are responsible for commissioning services for people with inflammatory bowel disease (IBD).</p><p> </p><p>To support local commissioning, the National Institute for Health and Care Excellence (NICE) has published best practice guidance for the timely and accurate diagnosis, treatment care and support for patients with IBD.</p><p> </p><p>NICE has published the guidance ’Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel’ which recommends that that faecal calprotectin testing as an option to help support clinicians distinguish between IBD and irritable bowel syndrome.</p><p> </p><p>Faecal calprotectin testing will therefore help decide who should be referred for colonoscopy (the Gold Standard diagnostic test) and who may be amenable to management in primary care. Primary and secondary care clinicians are expected to follow the good practice guidelines and the quality standard.</p><p> </p><p>NHS England commissions specialised Intestinal Failure Services. A number of these centres are currently involved in multidisciplinary training of health professionals in specialised IBD care. In addition, the Association of Coloproctology of Great Britain and Ireland are currently in the process of setting out national standards for surgical management of IBD. Patients are managed by a multidisciplinary team (MDT) with the necessary expertise to enable appropriate monitoring, support and advice necessary to manage the side effects of treatment, flare-ups and to review and maintain remission. MDT support and the associated diagnostic and investigative resource necessary for IBD patient care will usually be found in secondary care settings.</p><p> </p><p>General practitioners and clinicians are expected to take account of relevant NICE guidance to ensure that patients with suspected inflammatory bowel disease are referred quickly and efficiently, and have a specialist assessment within four weeks of referral.</p><p> </p><p>The NICE guidelines are available at the following links:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085" target="_blank">www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085</a></p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725" target="_blank">www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 136439 136442 136444 question first answered 23/04/2018 15:18:40 answering member 4067 label Biography information for Steve Brine
tabling member	4464 label Biography information for Melanie Onn

886247

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps (a) his Department and (b) NHS England are taking to improve the training for healthcare professionals in primary care to (i) diagnose and (ii) manage inflammatory bowel disease.
tabling member constituency	Great Grimsby
tabling member printed	Melanie Onn
uin	136442
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>NHS England and clinical commissioning groups (CCGs) are responsible for commissioning services for people with inflammatory bowel disease (IBD).</p><p> </p><p>To support local commissioning, the National Institute for Health and Care Excellence (NICE) has published best practice guidance for the timely and accurate diagnosis, treatment care and support for patients with IBD.</p><p> </p><p>NICE has published the guidance ’Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel’ which recommends that that faecal calprotectin testing as an option to help support clinicians distinguish between IBD and irritable bowel syndrome.</p><p> </p><p>Faecal calprotectin testing will therefore help decide who should be referred for colonoscopy (the Gold Standard diagnostic test) and who may be amenable to management in primary care. Primary and secondary care clinicians are expected to follow the good practice guidelines and the quality standard.</p><p> </p><p>NHS England commissions specialised Intestinal Failure Services. A number of these centres are currently involved in multidisciplinary training of health professionals in specialised IBD care. In addition, the Association of Coloproctology of Great Britain and Ireland are currently in the process of setting out national standards for surgical management of IBD. Patients are managed by a multidisciplinary team (MDT) with the necessary expertise to enable appropriate monitoring, support and advice necessary to manage the side effects of treatment, flare-ups and to review and maintain remission. MDT support and the associated diagnostic and investigative resource necessary for IBD patient care will usually be found in secondary care settings.</p><p> </p><p>General practitioners and clinicians are expected to take account of relevant NICE guidance to ensure that patients with suspected inflammatory bowel disease are referred quickly and efficiently, and have a specialist assessment within four weeks of referral.</p><p> </p><p>The NICE guidelines are available at the following links:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085" target="_blank">www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085</a></p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725" target="_blank">www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 136435 136439 136444 question first answered 23/04/2018 15:18:40 answering member 4067 label Biography information for Steve Brine
tabling member	4464 label Biography information for Melanie Onn

886249

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the NICE Quality Standard on inflammatory bowel disease, what steps he is taking to ensure that patients with suspected inflammatory bowel disease receive a specialist assessment within four weeks of referral.
tabling member constituency	Great Grimsby
tabling member printed	Melanie Onn
uin	136444
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>NHS England and clinical commissioning groups (CCGs) are responsible for commissioning services for people with inflammatory bowel disease (IBD).</p><p> </p><p>To support local commissioning, the National Institute for Health and Care Excellence (NICE) has published best practice guidance for the timely and accurate diagnosis, treatment care and support for patients with IBD.</p><p> </p><p>NICE has published the guidance ’Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel’ which recommends that that faecal calprotectin testing as an option to help support clinicians distinguish between IBD and irritable bowel syndrome.</p><p> </p><p>Faecal calprotectin testing will therefore help decide who should be referred for colonoscopy (the Gold Standard diagnostic test) and who may be amenable to management in primary care. Primary and secondary care clinicians are expected to follow the good practice guidelines and the quality standard.</p><p> </p><p>NHS England commissions specialised Intestinal Failure Services. A number of these centres are currently involved in multidisciplinary training of health professionals in specialised IBD care. In addition, the Association of Coloproctology of Great Britain and Ireland are currently in the process of setting out national standards for surgical management of IBD. Patients are managed by a multidisciplinary team (MDT) with the necessary expertise to enable appropriate monitoring, support and advice necessary to manage the side effects of treatment, flare-ups and to review and maintain remission. MDT support and the associated diagnostic and investigative resource necessary for IBD patient care will usually be found in secondary care settings.</p><p> </p><p>General practitioners and clinicians are expected to take account of relevant NICE guidance to ensure that patients with suspected inflammatory bowel disease are referred quickly and efficiently, and have a specialist assessment within four weeks of referral.</p><p> </p><p>The NICE guidelines are available at the following links:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085" target="_blank">www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085</a></p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725" target="_blank">www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 136435 136439 136442 question first answered 23/04/2018 15:18:40 answering member 4067 label Biography information for Steve Brine
tabling member	4464 label Biography information for Melanie Onn

869377

registered interest
date	22/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 March to Question 132917, on Inflammatory Bowel Disease, if his Department will take further steps to ensure that every GP is made aware of the toolkit.
tabling member constituency	Great Grimsby
tabling member printed	Melanie Onn
uin	133891
answer	answer is ministerial correction date of answer 27/03/2018 answer text <p>It is not the role of the Department to directly promote clinical toolkits to clinicians. As set out in the previous answer, the developers of the toolkit, Crohn’s and Colitis UK with the Royal College of General Practitioners, have undertaken a range of activities to promote general practitioners’ awareness of the new resource following its launch last summer.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/03/2018 16:18:17 answering member 4067 label Biography information for Steve Brine
tabling member	4464 label Biography information for Melanie Onn

864434

registered interest
date	15/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that GPs receive a copy of Crohn's & Colitis UK's latest Inflammatory Bowel Disease toolkit to improve (a) awareness, (b) early diagnosis and (b) treatment plans for that condition.
tabling member constituency	Great Grimsby
tabling member printed	Melanie Onn
uin	132917
answer	answer is ministerial correction date of answer 20/03/2018 answer text <p>In August 2017, Crohn’s and Colitis UK in partnership with the Royal College of General Practitioners (RCGP) launched a new Inflammatory Bowel Disease (IBD) toolkit: an online resource for general practitioners (GPs) and healthcare professionals designed to improve understanding of Crohn’s Disease and Ulcerative Colitis, collectively known as IBD. The Toolkit was developed as part of a 12 month project on IBD, and includes a range of resources for GPs to improve detection of inflammatory bowel disease and to support primary care clinicians in treating, managing and referring patients with the condition.</p><p> </p><p>The Toolkit was promoted at events across the United Kingdom and an IBD Twitter chat with an expert panel was held in February 2018. The Toolkit, regional events and Twitter session were all promoted to GPs via the RCGP website and newsletter and more widely by Crohn’s and Colitis UK. The Toolkit can be found at the following link:</p><p> </p><p><a href="http://www.rcgp.org.uk/clinical-and-research/resources/toolkits/inflammatory-bowel-disease-toolkit.aspx" target="_blank">www.rcgp.org.uk/clinical-and-research/resources/toolkits/inflammatory-bowel-disease-toolkit.aspx</a></p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/03/2018 16:31:16 answering member 4067 label Biography information for Steve Brine
tabling member	4464 label Biography information for Melanie Onn

855729

registered interest
date	05/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, What assessment (a) his Department and (b) NHS England has made of the potential resource efficiencies of redesigning NHS Inflammatory Bowel Disease services outside of the hospital setting.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	131035
answer	answer is ministerial correction date of answer 13/03/2018 answer text <p>No assessment has been made. The majority of services for people with Crohn’s disease or ulcerative colitis, which are collectively known as inflammatory bowel disease (IBD), are planned and delivered locally by clinical commissioning groups. NHS England commissions services for a small proportion of patients requiring complex surgery either because of their previous surgical history or because of the nature of their disease.</p><p> </p><p>To support local National Health Service deliver services for people with IBD, the National Institute for Health and Care Excellence (NICE) has published best practice in the diagnosis, treatment care and support of patients with Crohn’s diseases and ulcerative colitis in its guidance Crohn’s Disease Management in Adults, Children and Young People, published in October 2012 (updated in May 2016), and Ulcerative Colitis Management in Adults, Children and Young People, published in June 2013.</p><p> </p><p>IBD can cause serious complications and damage requiring surgery. The condition can also impact on the wider health and wellbeing of patients and is also linked to the development other serious conditions. NICE recommends patients are managed by a multidisciplinary team (MDT) with the necessary expertise to enable appropriate monitoring, support and advice necessary to manage the side effects of treatment, flare-ups and to review and maintain remission. MDT support, and the associated diagnostic and investigative resource necessary for IBD patient care will usually be found in secondary care settings. Both sets of NICE guidance can be found at the following links:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085" target="_blank">www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085</a></p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725" target="_blank">www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 13/03/2018 13:45:59 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon